Avedro Announces CE Mark for its Newest Riboflavin Formulations
The First Complete Family of Cross-linking Products
Ring My BEL: Selventa Releases Biological Expression Language
By Kevin Davies
May 23, 2012 | With a recent rebranding and evolving business model, Selventa—the company formerly known as Genstruct—has decided to release a key knowledge engineering asset to the scientific community.
Ensemble Therapeutics and Genentech Initiate Collaboration to Discover Macrocyclic Drug Candidates
Collaboration to deploy Ensemble's innovative platform for Genentech's biological targets
Recent Flurry of New Life Science Funds Aim to Start Bridging the Valley of Death
It remains to be seen whether these partnerships will succeed in advancing more medicines.
Biofuels at the Tipping Point
AeroShot Delivers the Taste of Chocolate Without the Calories
AeroDesigns, Inc. announces the U.S. launch of its zero-calorie, aerodynamic chocolate product invented by Harvard professor David Edwards
LS9 Announces Florida Plant Grand Opening and Receives $4.5 million from Florida Opportunity Fund
South san francisco, CA (May 14, 2012) – LS9, Inc., a technology leader in the development of renewable and sustainable products, today announced an investment from the Florida Opportunity Fund's (FOF) Clean Energy Investment Program, and the Grand Opening plans for its facility in Okeechobee, Florida.
Helicos BioSciences Corporation Settles its Patent Litigation Against Pacific Biosciences, Inc.
Litigation Against Illumina, Life Technologies Continues
Affinnova Announces Record Sales
WALTHAM, Mass., May 17, 2012 (BUSINESS WIRE) -- Affinnova, Inc., the global leader in innovation software and services, has announced record sales for the prior twelve months ending March, 2012. Total sales increased 43% compared to the previous 12-month period. Non-U.S. sales rose to 18% of the business overall, as Affinnova has aggressively expanded its operations in Europe, hiring staff in the United Kingdom, France and Germany.